In HEK293 cells expressing the GAT1 epilepsy-linked A288V variant (one of the most commonly recurrent mutations identified in patients; cf., Figure 2), we found a rather modest increase in uptake upon exposure to tiagabine. The gene discussed is SLC6A1; the disease is epilepsy.